Ortiz-Maldonado V, Liang EC, Huang JJ, Jeon Y, Hirayama AV, Kimble EL, Portuguese AJ, Khouderchah C, Braathen K, Torkelson A, Kirchmeier D, Shadman M, Maloney DG, Riddell SR, Turtle CJ, Gauthier J. A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma. Haematologica; https://doi.org/10.3324/haematol.2025.300321 [Early view].